Furthermore, simultaneously blocking both VEGF and Dll4 can have more potent effects in a variety of tumour models than blockade of either factor alone (Ridgway et al, 2006; I Noguera-Troise et al, unpublished results), including this sarcoma model. The gene discussed is DLL4; the disease is sarcoma.